At the end of the financial year 2025, PT Indofarma (Persero), Tbk recorded a gross loss of approximately ** billion Indonesian rupiah. The company is a subsidiary of PT Bio Farma (Persero), a state-owned pharmaceutical enterprise, and one of the leading companies in the pharmaceutical industry in Indonesia.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PT Indofarma (Persero), Tbk. (June 3, 2026). Gross profit of Indofarma from the financial years 2018 to 2025 (in billion Indonesian rupiah) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1460181/indofarma-gross-profit/
PT Indofarma (Persero), Tbk. "Gross profit of Indofarma from the financial years 2018 to 2025 (in billion Indonesian rupiah)." Chart. June 3, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1460181/indofarma-gross-profit/
PT Indofarma (Persero), Tbk. (2026). Gross profit of Indofarma from the financial years 2018 to 2025 (in billion Indonesian rupiah). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1460181/indofarma-gross-profit/
PT Indofarma (Persero), Tbk. "Gross Profit of Indofarma from The Financial Years 2018 to 2025 (in Billion Indonesian Rupiah)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 3 Jun 2026, /statistics/1460181/indofarma-gross-profit/
PT Indofarma (Persero), Tbk, Gross profit of Indofarma from the financial years 2018 to 2025 (in billion Indonesian rupiah) ÌÇÐÄÆƽâ°æ, /statistics/1460181/indofarma-gross-profit/ (last visited July 20, 2026)
Gross profit of Indofarma from the financial years 2018 to 2025 (in billion Indonesian rupiah) [Graph], PT Indofarma (Persero), Tbk, June 3, 2026. [Online]. Available: /statistics/1460181/indofarma-gross-profit/
